Jialin Sun

Prof. Jialin Sun

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2024 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
YWYu-Yuan Wang
Yu-Yuan Wang
WZWei-Wen Zhang
Wei-Wen Zhang
ZLZe-Xi Lu
Ze-Xi Lu
JSJialin Sun
Jialin Sun
MJMing-Xia Jing
Ming-Xia Jing
Background: A lack of health resources is a common problem after the outbreak of infectious diseases, and resource optimization is an important means to solve the lack of prevention and control capacity caused by resource constraints. This study systematically evaluated the similarities and differences in the application of coronavirus disease (COVID-19) resource allocation models and analyzed the effects of different optimal resource allocations on epidemic control. Methods: A systematic literature search was conducted of CNKI, WanFang, VIP, CBD, PubMed, Web of Science, Scopus and Embase for articles published from January 1, 2019, through November 23, 2023. Two reviewers independently evaluated the quality of the included studies, extracted and cross-checked the data. Moreover, publication bias and sensitivity analysis were evaluated. Results: A total of 22 articles were included for systematic review; in the application of optimal allocation models, 59.09% of the studies used propagation dynamics models to simulate the allocation of various resources, and some scholars also used mathematical optimization functions (36.36%) and machine learning algorithms (31.82%) to solve the problem of resource allocation; the results of the systematic review show that differential equation modeling was more considered when testing resources optimization, the optimization function or machine learning algorithm were mostly used to optimize the bed resources; the meta-analysis results showed that the epidemic trend was obviously effectively controlled through the optimal allocation of resources, and the average control efficiency was 0.38(95%CI 0.25–0.51); Subgroup analysis revealed that the average control efficiency from high to low was health specialists 0.48(95%CI 0.37–0.59), vaccines 0.47(95%CI 0.11–0.82), testing 0.38(95%CI 0.19–0.57), personal protective equipment (PPE) 0.38(95%CI 0.06–0.70), beds 0.34(95%CI 0.14–0.53), medicines and equipment for treatment 0.32(95%CI 0.12–0.51); Funnel plots and Egger’s test showed no publication bias, and sensitivity analysis suggested robust results. Conclusion: When the data are insufficient and the simulation time is short, the researchers mostly use the constructor for research; When the data are relatively sufficient and the simulation time is long, researchers choose differential equations or machine learning algorithms for research. In addition, our study showed that control efficiency is an important indicator to evaluate the effectiveness of epidemic prevention and control. Through the optimization of medical staff and vaccine allocation, greater prevention and control effects can be achieved.

9 October 2025 in Food, Nutrition and Health
Verified
Journal Article
Open access
PDF file
GEGabriela Maria Villagrán Escobar
Gabriela Maria Villagrán Escobar
LLLi Li
Li Li
WCWenlin Cheng
Wenlin Cheng
ZLZixuan Li
Zixuan Li
QGQin Gao
Qin Gao
LHLiping Hao
Liping Hao
Gestational diabetes mellitus (GDM) is a prevalent metabolic condition associated with pregnancy, defined by reduced glucose tolerance and insulin resistance (IR), which may have long-term consequences for both mother's and offspring's health.Recent evidence highlights the critical role of natural bioactive compounds, particularly anthocyanins—a group of flavonoid compounds abundant in berries—in regulating glucose metabolism and reducing GDM risk through their hypoglycemic, antioxidant, and anti-inflammatory properties. This review analyses the current knowledge about the effects of anthocyanins on glucose metabolism in the context of GDM. In vitro and in vivo studies suggest that anthocyanins enhance insulin sensitivity by promoting AMPK activation, increasing GLUT4 translocation, and lowering oxidative stress and proinflammatory cytokines, including TNF-α and IL-6. Moreover, anthocyanins inhibit the metabolic processes of α-glucosidase and α-amylase, thereby lowering postprandial hyperglycemia. Despite the lack of clinical research focused on GDM, preliminary trials including pregnant women predisposed to metabolic diseases indicate beneficial impacts on antioxidant capacity, lipid metabolism, and adipokine profiles. These findings indicate that anthocyanins may act as a beneficial supplement in the dietary control of GDM. Nevertheless, additional clinical trials are required to establish appropriate dosages, evaluate long-term safety, and validate their therapeutic efficacy during pregnancy.

18 March 2024 in Infectious Diseases and Therapy
Verified
Journal Article
Open access
PDF file
YWYu-Yuan Wang
Yu-Yuan Wang
WZWei-Wen Zhang
Wei-Wen Zhang
ZLZe-Xi Lu
Ze-Xi Lu
JSJialin Sun
Jialin Sun
MJMing-Xia Jing
Ming-Xia Jing
Introduction The 2019 novel coronavirus (COVID-19) has been recognized as the most severe human infectious disease pandemic in the past century. To enhance our ability to control potential infectious diseases in the future, this study simulated the influence of nucleic acid testing on the transmission of COVID-19 across varied scenarios. Additionally, it assessed the demand for nucleic acid testing under different circumstances, aiming to furnish a decision-making foundation for the implementation of nucleic acid screening measures, the provision of emergency materials, and the allocation of human resources. Methods Considering the transmission dynamics of COVID-19 and the preventive measures implemented by countries, we explored three distinct levels of epidemic intensity: community transmission, outbreak, and sporadic cases. Integrating the theory of scenario analysis, we formulated six hypothetical epidemic scenarios, each corresponding to possible occurrences during different phases of the pandemic. We developed an improved SEIR model, validated its accuracy using real-world data, and conducted a comprehensive analysis and prediction of COVID-19 infections under these six scenarios. Simultaneously, we assessed the testing resource requirements associated with each scenario. Results We compared the predicted number of infections simulated by the modified SEIR model with the actual reported cases in Israel to validate the model. The root mean square error (RMSE) was 350.09, and the R-squared (R2) was 0.99, indicating a well-fitted model. Scenario 4 demonstrated the most effective prevention and control outcomes. Strengthening non-pharmaceutical interventions and increasing nucleic acid testing frequency, even under low testing capacity, resulted in a delayed epidemic peak by 78 days. The proportion of undetected cases decreased from 77.83% to 31.21%, and the overall testing demand significantly decreased, meeting maximum demand even with low testing capacity. The initiation of testing influenced case detection probability. Under high testing capacity, increasing testing frequency elevated the detection rate from 36.40% to 77.83%. Nucleic acid screening proved effective in reducing the demand for testing resources under diverse epidemic prevention and control strategies. While effective interventions and nucleic acid screening measures substantially diminished the demand for testing-related resources, varying degrees of insufficient testing capacity may still persist. Conclusions The nucleic acid detection strategy proves effective in promptly identifying and isolating infected individuals, thereby mitigating the infection peak and extending the time to peak. In situations with constrained testing capacity, implementing more stringent measures can notably decrease the number of infections and alleviate resource demands. The improved SEIR model demonstrates proficiency in predicting both reported and unreported cases, offering valuable insights for future infection risk assessments. Rapid evaluations of testing requirements across diverse scenarios can aptly address resource limitations in specific regions, offering substantial evidence for the formulation of future infectious disease testing strategies.

29 July 2024 in Risk Analysis
Verified
Journal Article
Open access
WZWei‐Wen Zhang
Wei‐Wen Zhang
YHYan‐Ran Huang
Yan‐Ran Huang
YWYu‐Yuan Wang
Yu‐Yuan Wang
ZLZe‐Xi Lu
Ze‐Xi Lu
JSJialin Sun
Jialin Sun
MJMing‐Xia Jing
Ming‐Xia Jing
We constructed a rapid infection risk assessment model for contacts of COVID‐19. The improved Wells–Riley model was used to estimate the probability of infection for contacts of COVID‐19 in the same place and evaluate their risk grades. We used COVID‐19 outbreaks that were documented to validate the accuracy of the model. We analyzed the relationship between controllable factors and infection probability and constructed common scenarios to analyze the infection risk of contacts in different scenarios. The model showed the robustness of the fitting (mean relative error = 5.89%, mean absolute error = 2.03%, root mean squared error = 2.03%, R2 = 0.991). We found that improving ventilation from poorly ventilated to naturally ventilated and wearing masks can reduce the probability of infection by about two times. Contacts in places of light activity, loud talking or singing, and heavy exercise, oral breathing (e.g., gyms, KTV, choirs) were at higher risk of infection. The model constructed in this study can quickly and accurately assess the infection risk grades of COVID‐19 contacts. Simply opening doors and windows for ventilation can significantly reduce the risk of infection in certain places. The places of light activity, loud talking or singing, and heavy exercise, oral breathing, should pay more attention to prevent and control transmission of the epidemic.

2 November 2026 in Healthcare
Verified
Journal Article
Open access
PDF file
XWXiaolong Wang
Xiaolong Wang
MMMaiwulamujiang Maimaitiyiming
Maiwulamujiang Maimaitiyiming
LXLin Xia
Lin Xia
YYYuting Yang
Yuting Yang
JSJialin Sun
Jialin Sun
MJMingxia Jing Jing
Mingxia Jing Jing
Objective: Cardiometabolic multimorbidity (CMM) typically evolves from a healthy state to an initial cardiometabolic disease (FCMD) and subsequently to CMM. The triglyceride-glucose-body mass index (TyG-BMI) is a composite surrogate marker of insulin resistance. However, its associations with incident cardiometabolic outcomes across different baseline CMD profiles remain insufficiently characterized. Using data from the China Health and Retirement Longitudinal Study (CHARLS), we examined the associations of TyG-BMI with incident first cardiometabolic disease (FCMD) among participants without CMD at baseline and incident CMM among those with one CMD at baseline. Methods: Participants were classified into two groups according to their baseline CMD status: the healthy-to-FCMD group and the FCMD-to-CMM group. Separate Cox proportional hazards models were fitted to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for each group. Dose–response relationships were evaluated using restricted cubic splines (RCS). Sensitivity analyses included a two-year landmark analysis and a complete-case analysis. Results: The healthy-to-FCMD group included 5707 participants (median follow-up: 9.0 years; 2599 incident FCMD cases), whereas the FCMD-to-CMM group included 2256 participants (median follow-up: 7.0 years; 1040 incident CMM cases). After adjustment for potential confounders, the HRs for the highest TyG-BMI quartile (Q4) compared with the lowest quartile (Q1) were 2.268 (95% CI: 2.022–2.544) for FCMD and 1.895 (95% CI: 1.574–2.282) for CMM. Each 1-standard deviation (SD) increase in TyG-BMI was associated with a 38.5% higher hazard of FCMD (HR = 1.385, 95% CI: 1.332–1.440) and a 31.5% higher hazard of CMM (HR = 1.315, 95% CI: 1.232–1.404). RCS analyses indicated positive associations between TyG-BMI and both outcomes, with no statistically significant evidence of nonlinearity within the observed range (p for nonlinearity = 0.963 and 0.150, respectively). The associations were generally consistent in sensitivity analyses. Conclusion: Higher TyG-BMI was associated with an increased hazard of incident FCMD among participants without CMD at baseline and incident CMM among those with one CMD at baseline. These findings provide complementary observational evidence on cardiometabolic risk across different baseline CMD profiles.